| Interop Technologies Wins CX Catalyst Award for Growth for RCS Enablement Services Suite |
Globe Newswire |
11/04 |
08:05 |
| Studio City International Holdings Limited Announces Unaudited Third Quarter 2026 Earnings |
Globe Newswire |
11/04 |
08:01 |
| Melco Resorts Announces Unaudited Third Quarter 2026 Earnings |
Globe Newswire |
11/04 |
08:00 |
| Phathom Pharmaceuticals to Participate in November Investor Conferences |
Globe Newswire |
11/04 |
08:00 |
| Pivotal Phase 2 Rezatapopt PYNNACLE Data to Be Featured in Late-Breaking Oral Presentation at ENA 2026 |
Globe Newswire |
11/04 |
08:00 |
| Actuate Therapeutics to Present Promising Preclinical Data Demonstrating Antitumor and Immune Activation Activity of Elraglusib Oral Tablet in Advanced Melanoma Models at ENA 2026 |
Globe Newswire |
11/04 |
08:00 |
| Aeroméxico October 2026 Traffic Results |
Globe Newswire |
11/04 |
08:00 |
| Jasper Therapeutics Announces 1-for-30 Reverse Stock Split |
Globe Newswire |
11/04 |
08:00 |
| Septerna Announces Selection of SEP-204 as Development Candidate for Graves' Disease and TED and Reports Preclinical Data at the 2026 American Thyroid Association Annual Meeting |
Globe Newswire |
11/04 |
08:00 |
| Scribe Therapeutics to Present Updated Data on PCSK9-Targeting Epigenetic Silencing and LPA-Targeting Gene Editing Programs at American Heart Association (AHA) Scientific Sessions 2026 |
Globe Newswire |
11/04 |
08:00 |
| EquityProtect Partners with Real Estate Business Services, LLC to Bring Preventive Property-Fraud Protection to California REALTORS® |
Globe Newswire |
11/04 |
08:00 |
| Bond CEO to Host Investor Webinar on Strategic Financial Realignment |
Globe Newswire |
11/04 |
08:00 |
| Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE® (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome |
Globe Newswire |
11/04 |
08:00 |
| Noom Names Leading Awe Researcher Dacher Keltner as Advisor, Announces New National Awe Day |
Globe Newswire |
11/04 |
08:00 |
| NewcelX Enters into Binding Term Sheet to Divest Legacy Mazindol Portfolio (CVR), Providing for Upfront Cash, Equity Ownership and Up to $55 Million in Potential Milestone Payments |
Globe Newswire |
11/04 |
08:00 |
| Twin Disc Announces First Quarter Results |
Globe Newswire |
11/04 |
08:00 |
| UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights |
Globe Newswire |
11/04 |
08:00 |
| Electra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in London |
Globe Newswire |
11/04 |
08:00 |
| Sutro Biopharma to Participate in Upcoming Investor Conferences |
Globe Newswire |
11/04 |
08:00 |
| Elicio Therapeutics to Host Virtual KOL Event on November 11, 2026: ELI-002 7P for Metastatic and Neoadjuvant PDAC |
Globe Newswire |
11/04 |
08:00 |
| Global Indemnity Group, LLC Reports Financial Results for the three and nine months ended September 30, 2026 |
Globe Newswire |
11/04 |
08:00 |
| Genius Group Advances ASX Dual Listing, Expands GENIUSpark AI Data Center Initiative to Australia |
Globe Newswire |
11/04 |
08:00 |
| Processa Pharmaceuticals Announces Key Leadership Appointments |
Globe Newswire |
11/04 |
08:00 |
| Intellia Therapeutics Completes Enrollment in Phase 3 MAGNITUDE-2 Trial of Nexiguran Ziclumeran (Nex-z) for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (ATTRv-PN) |
Globe Newswire |
11/04 |
08:00 |
| The Latest: Voters give Democrats control of Congress in rebuke to Trump |
AP Online |
11/04 |
07:56 |
